Medication info

Telmisartan 80 mg Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle
Approval status
Expired

MFDS item code 201906392 · Approved 2019.09.10

This product's status changed to Expired on 2024.09.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medicine is coadministered with thiazide diuretics such as hydrochlorothiazide, additional blood pressure-lowering effects are observed. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • clinical evidence of end-organ damage in high-risk diabetes
View approved original text

This medication is used to treat essential hypertension. Additionally, it helps to reduce the risk of myocardial infarction, stroke, and death from cardiovascular diseases in patients over 55 years old who are at high risk for cardiovascular diseases. It is particularly useful in patients with a history of coronary artery disease, peripheral artery disease, stroke, or high-risk diabetes. It is effective as an alternative therapy when ACE inhibitors cannot be used. This medication aids in managing hypertension and protecting cardiovascular health simultaneously, improving the overall health of patients.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medicine is coadministered with thiazide diuretics such as hydrochlorothiazide, additional blood pressure-lowering effects are observed. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose serious risks of harm or death to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals allergic to this drug or its components, in pregnant or breastfeeding women, patients with severe liver impairment, patients with hereditary angioedema, or patients with severe renal impairment. Elderly patients, patients with high potassium levels, patients with liver impairment, patients with heart valve disease or hypertrophic cardiomyopathy, gastrointestinal disease patients, and those with renal artery hypertension should take this medication with caution. During treatment with this drug, side effects such as infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, dizziness, hypotension, dyspepsia, liver dysfunction, skin rashes, myalgia, and renal function impairment may occur. Any unusual symptoms should be discussed with a doctor immediately. Particularly, blood pressure may drop too low, leading to symptoms of shock or fainting, so careful monitoring is needed, and appropriate treatment should be applied if necessary. Patients with reduced kidney function should regularly check potassium and creatinine levels through blood tests. Dialysis patients may take the medication without dose adjustments, but their condition should be closely monitored. Patients with reduced blood volume or those taking diuretics are at risk for hypotension, so it is essential to normalize their condition before administration. This medication may enhance blood pressure-lowering effects when taken with other antihypertensives, so consultation with healthcare professionals is necessary. Particular caution is needed when used concurrently with lithium, digoxin, ramipril, potassium-sparing diuretics, and non-steroidal anti-inflammatory drugs, as the risk of side effects may increase. Women who are pregnant or planning to become pregnant should avoid using this medication, and breastfeeding women are also advised to avoid it. Safety and effectiveness have not been established in children under 18 years of age; therefore, it is not recommended for this population. In case of overdose, hypotension, dizziness, or acute renal failure may occur, requiring immediate medical attention. This medication should be kept out of the reach of children and should not be transferred to other containers. Caution should be taken while driving or operating machinery as drowsiness or dizziness may occur.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 111 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • depression
  • insomnia
  • anxiety
  • syncope
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • abnormal liver function
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • elevated serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • angioedema
  • severe hyperkalemia
  • renal failure
  • shock
  • syncope due to hypotension
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • cough
  • abnormal chest X-ray
  • rhabdomyolysis
  • myalgia
  • weakness
  • elevated serum and urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.